Art-175

N/A

Report date: 2025/06/11 11:17:32

Base Information

Drug NameArt-175
Drug Alias NameArtilysinengineered endolysin based therapy (Lisando/Katholieke Universiteit Leuven/AiCuris)Art-014Art-093Bat-072 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsMultidrug-Resistant InfectionGram-Positive Bacterial Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLysando AG
China Registration ClassN/A

Develop Information

Active CompaniesLysando AGKu LeuvenAicuris Anti-Infective Cures Gmbh
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii InfectionsMultidrug-Resistant InfectionGram-Positive Bacterial Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A